NXL104
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for NXL104, covering 2014-02-03 to 2018-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections [Phase 2]